de Leon, Jose <br/><br/>
Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels.  [electronic resource] 

 -  Schizophrenia research  Jan 2008 
 - 40-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0920-9964 
<br/><br/><label>Standard No.: </label>10.1016/j.schres.2007.10.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antipsychotic Agents--adverse effects<br/>Benzodiazepines--adverse effects<br/>Chlorpromazine--adverse effects<br/>Cross-Sectional Studies<br/>Dibenzothiazepines--adverse effects<br/>Female<br/>Gene Frequency<br/>Genetic Variation--genetics<br/>Genotype<br/>Humans<br/>Hypercholesterolemia--chemically induced<br/>Hyperlipidemias--chemically induced<br/>Hypertriglyceridemia--chemically induced<br/>Lipids--blood<br/>Male<br/>Olanzapine<br/>Oligonucleotide Array Sequence Analysis<br/>Pharmacogenetics<br/>Polymorphism, Single Nucleotide<br/>Psychotic Disorders--blood<br/>Quetiapine Fumarate<br/>Randomized Controlled Trials as Topic--statistics & numerical data